hVIVO Plc (HVO):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:hVIVO Plc (HVO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8052
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
hVIVO Plc (hVIVO), formerly Retroscreen Virology Ltd is a biopharma company that develops human-based analytical platform to accelerate drug discovery and development. The company enables organisations to discover drugs and diagnostics and accelerate new product development. It uses human disease model platform to study new drugs and investigate diseases. hVIVO offers services such as viral challenge study services, viral lab services, and target and biomarker discovery. The company offers lab services in the areas of virology, immunology and molecular biology. Its disease models comprise influenza research, human rhinoviruses research, respiratory syncytial virus research, and asthma research. The company serves pharmaceutical and biotech companies across the UK. hVIVO is headquartered in London, the UK.

hVIVO Plc (HVO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
hVIVO Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
hVIVO Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
hVIVO Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
hVIVO Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
hVIVO Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
hVIVO Plc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
PrEP Biopharm Raises USD32.4 Million in Series A Financing Round 10
PrEP Biopharm to Raise USD25 Million in Series A Financing 11
Partnerships 12
Hvivo and Seek Group Form Joint Venture 12
Activiomics Extends Research Agreement With Kyowa Hakko Kirin 14
Activiomics Enters Into Research Agreement With Kyowa Hakko 15
Activiomics Enters Into Drug Discovery Agreement With BioFocus 16
Equity Offering 17
Hvivo Raises USD31 Million in Private Placement of Shares 17
Retroscreen Virology to Raise USD56 Million in Private Placement of Shares 18
Retroscreen Virology Completes Private Placement Of Shares For US$40 Million 20
Retroscreen Virology Completes IPO Of Shares For US$24.3 Million 21
Acquisition 22
hVIVO Services Acquires 62.62% Stake in PrEP Biopharm for USD21.6 Million 22
Retroscreen Virology Acquires Activiomics for USD6.7 Million 23
hVIVO Plc – Key Competitors 25
hVIVO Plc – Key Employees 26
hVIVO Plc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Joint Venture 27
Recent Developments 28
Financial Announcements 28
Sep 20, 2018: hVIVO: Interim results for the six months ended 30 June 2018 28
Apr 19, 2018: hVIVO Announces Audited Preliminary Results for the Year Ended 31 December 2017 34
Sep 21, 2017: Hvivo: Half-year Financial Report For The Six Months Ended 30 June 2017 36
Apr 20, 2017: hVIVO: Audited Preliminary Results For The Year Ended 31 December 2016 37
Apr 20, 2017: hVIVO: Preliminary results for the year ended 31 December 2016 38
Corporate Communications 39
Oct 08, 2018: hVIVO reports Directorate change 39
Apr 19, 2018: HVIVO Announces Resignation Of Kym Denny As Chief Executive Officer 40
Oct 30, 2017: hVIVO: Trevor Phillips to assume role of Executive Chairman 41
Jun 20, 2017: HVIVO: Board Change 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
hVIVO Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
hVIVO Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
hVIVO Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
hVIVO Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
hVIVO Plc, Deals By Therapy Area, 2012 to YTD 2018 8
hVIVO Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PrEP Biopharm Raises USD32.4 Million in Series A Financing Round 10
PrEP Biopharm to Raise USD25 Million in Series A Financing 11
Hvivo and Seek Group Form Joint Venture 12
Activiomics Extends Research Agreement With Kyowa Hakko Kirin 14
Activiomics Enters Into Research Agreement With Kyowa Hakko 15
Activiomics Enters Into Drug Discovery Agreement With BioFocus 16
Hvivo Raises USD31 Million in Private Placement of Shares 17
Retroscreen Virology to Raise USD56 Million in Private Placement of Shares 18
Retroscreen Virology Completes Private Placement Of Shares For US$40 Million 20
Retroscreen Virology Completes IPO Of Shares For US$24.3 Million 21
hVIVO Services Acquires 62.62% Stake in PrEP Biopharm for USD21.6 Million 22
Retroscreen Virology Acquires Activiomics for USD6.7 Million 23
hVIVO Plc, Key Competitors 25
hVIVO Plc, Key Employees 26
hVIVO Plc, Subsidiaries 27
hVIVO Plc, Joint Venture 27

List of Figures
hVIVO Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
hVIVO Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
hVIVO Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
hVIVO Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
hVIVO Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
hVIVO Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
hVIVO Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
hVIVO Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[hVIVO Plc (HVO):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ZTE Corp:企業の戦略・SWOT・財務情報
    ZTE Corp - Strategy, SWOT and Corporate Finance Report Summary ZTE Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Hunan Corun New Energy Co Ltd (600478):電力:M&Aディール及び事業提携情報
    Summary Hunan Corun New Energy Co Ltd (Corun) is a battery manufacturing company that designs, research's, produces and commercializes materials and batteries. The company develops high quality energy materials, extension products and advanced batteries, among others. It also manufactures ultra-inte …
  • HSBC Holdings Plc:企業の戦略・SWOT・財務情報
    HSBC Holdings Plc - Strategy, SWOT and Corporate Finance Report Summary HSBC Holdings Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Shree Cement Limited:企業の戦略・SWOT・財務情報
    Shree Cement Limited - Strategy, SWOT and Corporate Finance Report Summary Shree Cement Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Gujarat Industries Power Co Ltd (GIPCL):企業の財務・戦略的SWOT分析
    Gujarat Industries Power Co Ltd (GIPCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • POSCO:企業の戦略・SWOT・財務情報
    POSCO - Strategy, SWOT and Corporate Finance Report Summary POSCO - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …
  • Arconic Inc (ARNC):企業の財務・戦略的SWOT分析
    Arconic Inc (ARNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • MTS Systems Corp (MTSC):企業の財務・戦略的SWOT分析
    Summary MTS Systems Corp (MTS) is an industrial equipment supplier that offers testing and sensing solutions. The company’s products include test components, actuators and hydraulic components, controllers, grips, fixtures and accessories, hydraulic power and distribution; environmental simulation s …
  • Nexstim Plc (NXTMH):医療機器:M&Aディール及び事業提携情報
    Summary Nexstim Plc (Nexstim) focuses on navigated, non-invasive brain stimulation therapy and diagnosis based on E-field navigated neuro stimulation technology (eTMS). Its NBS system applies the technology for pre-surgical mapping of the motor and speech cortices. It is also used for research, ther …
  • Iconix Brand Group Inc (ICON):企業の財務・戦略的SWOT分析
    Iconix Brand Group Inc (ICON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Transport for London:企業の戦略的SWOT分析
    Transport for London - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • UMW Holdings Berhad (UMW):石油・ガス:M&Aディール及び事業提携情報
    Summary UMW Holdings Bhd (UMW) is a diversified company. The company operates through its business divisions such as automotive, equipment, manufacturing and engineering, and oil and gas. Its automotive business manufactures, assembles, markets and distributes passenger cars and commercial vehicles. …
  • Village Super Market, Inc.:企業の戦略・SWOT・財務情報
    Village Super Market, Inc. - Strategy, SWOT and Corporate Finance Report Summary Village Super Market, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Viamet Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Viamet Pharmaceuticals Inc (Viamet), a subsidiary of Viamet Pharmaceuticals Holdings LLC is a provider of metalloenzyme inhibitors and antifungal agents. The company offers novel agents to treat both chronic and life threatening fungal infections. Its product pipeline includes clinical-stage …
  • Office Depot, Inc.:企業のM&A・事業提携・投資動向
    Office Depot, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Office Depot, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Motif BioSciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Motif BioSciences Inc (Motif), a subsidiary of Motif Bio Plc is a clinical stage biopharmaceutical company that manufactures novel antibiotics designed to treat life-threatening infections caused by multi-drug resistant bacteria. The company’s product programs include MTF-001, iclaprim, and …
  • The TJX Companies, Inc. (TJX):企業の財務・戦略的SWOT分析
    The TJX Companies, Inc. (TJX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • African Phoenix Investments Ltd:企業の戦略・SWOT・財務分析
    African Phoenix Investments Ltd - Strategy, SWOT and Corporate Finance Report Summary African Phoenix Investments Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Prescient Therapeutics Ltd (PTX):企業の財務・戦略的SWOT分析
    Summary Prescient Therapeutics Ltd (Prescient Therapeutics), formerly Virax Holdings Ltd, is a clinical stage oncology company that develops novel drugs for the treatment of solid and hematological cancers. The company’s lead drug candidate includes PTX-200, a potent small molecule inhibitor of the …
  • National Bank of Kuwait SAK:企業の戦略・SWOT・財務情報
    National Bank of Kuwait SAK - Strategy, SWOT and Corporate Finance Report Summary National Bank of Kuwait SAK - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆